IP Library Granted Patent US 9,889,113
Granted Patent B2
US 9,889,113 · App. 15/694,876 · Granted Feb 13, 2018

Method for reversing, preventing, delaying or stabilizing soft tissue calcification

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,889,113
App. No.
15/694,876
Granted
Feb 13, 2018
Kind
B2
Abstract

The present invention provides methods of treating soft tissue calcification in a subject, comprising a step of administering to said subject an effective amount of ferric organic compound, such as ferric citrate. The claimed methods may prevent, reverse, delay or stabilize soft tissue calcification in a subject having chronic kidney disease. Affected soft tissue calcification includes soft tissue calcification in the joint, skin, eye, in cardiovascular system such as heart valve, myocardium, coronary arteries and arteriole, or in internal organs such as kidney and lung.

Claims (13)

1. A method of reversing soft tissue calcification in a subject, comprising administering to said subject an effective amount of ferric citrate having a BET active surface area of at least about 16 m 2 /g, wherein soft tissue calcification is reversed.

2. The method of claim 1 , wherein the ferric citrate has a BET active surface area of about 16 m 2 /g to about 20 m 2 /g.

3. The method of claim 1 , wherein the soft tissue is selected from soft tissue in a joint, the skin, an eye, a heart valve, the myocardium, a coronary artery, a coronary arteriole, a kidney and a lung.

4. The method of claim 3 , wherein the soft tissue is eye tissue.

5. The method of claim 1 , wherein the ferric citrate is formulated for oral administration.

6. The method of claim 5 , wherein the ferric citrate is formulated as a tablet, a powder, a suspension, an emulsion, a capsule, a lozenge, a granule, a troche, a pill, a liquid, a spirit or a syrup.

7. The method of claim 1 , wherein the effective amount of ferric citrate is 2 grams per day.

8. The method of claim 1 , wherein the effective amount of ferric citrate is 4 grams per day.

9. The method of claim 1 , wherein the effective amount of ferric citrate is 6 grams per day.

10. The method of claim 1 , wherein calcification is reversed by up to 40%.

11. The method of claim 1 , wherein calcification is reversed by up to 56%.

12. The method of claim 1 , wherein calcification is reversed by up to 67%.

13. The method of claim 1 , wherein calcification is reversed by up to 100%.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2017
From: CHAN, KEITH; TOWN, WINSTON
To: GLOBOASIA, LLC
Reel/Frame 043816/0416 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 9, 2017
From: CHIANG, SHOU SHAN
To: PANION & BF BIOTECH, INC.
Reel/Frame 043816/0521 →
NUNC PRO TUNC ASSIGNMENT Recorded Oct 9, 2017
From: GLOBOASIA, LLC
To: PANION & BF BIOTECH, INC.
Reel/Frame 043816/0669 →